Terms: = Lymphoma AND KCNJ5, ENSG00000120457, 3762, P48544, KIR3_4, KATP1, GIRK4
5 results:
1. [Anti-CD19 CART (C-CAR011) Therapy for Relapsed or Refractory B-Cell Non-Hodgkin lymphoma].
Zhang L; Zhang Y; Zhou DB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1141-1147. PubMed ID: 34362494
[TBL] [Abstract] [Full Text] [Related]
2. Hypothermia Effectively Treats Tumors with Temperature-Sensitive p53 Mutations.
Lu J; Chen L; Song Z; Das M; Chen J
Cancer Res; 2021 Jul; 81(14):3905-3915. PubMed ID: 33687951
[TBL] [Abstract] [Full Text] [Related]
3. Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression.
Chen RL; Zhao J; Zhang XC; Lou NN; Chen HJ; Yang X; Su J; Xie Z; Zhou Q; Tu HY; Zhong WZ; Yan HH; Guo WB; Wu YL; Yang JJ
BMC Cancer; 2018 Nov; 18(1):1171. PubMed ID: 30477470
[TBL] [Abstract] [Full Text] [Related]
4. Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma.
Shimoni A; Zwas ST; Oksman Y; Hardan I; Shem-Tov N; Rand A; Yerushalmi R; Avigdor A; Ben-Bassat I; Nagler A
Bone Marrow Transplant; 2008 Feb; 41(4):355-61. PubMed ID: 18026153
[TBL] [Abstract] [Full Text] [Related]
5. Relationship of urinary pseudouridine and 1-methyladenosine to activity of leukemia and lymphoma.
Itoh K; Konno T; Sasaki T; Ishiwata S; Ishida N; Misugaki M
Clin Chim Acta; 1992 Mar; 206(3):181-9. PubMed ID: 1606704
[TBL] [Abstract] [Full Text] [Related]
